Ομορφιά

Reuters exclusively reports Pfizer’s COVID-19 vaccine supply to the EU 30% below plans

Health

Reuters exclusively reported that Pfizer has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, leaving it about one-third short of the supplies it had expected by now from the U.S. company. The delay is another blow to the EU, which has also been hit by delays in deliveries from Anglo-Swedish drugmaker AstraZeneca and U.S. company Moderna, and had also faced earlier delays on the Pfizer vaccine. It also raises questions about the rationale of an EU vaccine export control scheme which was set up in late January to ensure timely deliveries but has not yet been activated, despite the supply shortfalls.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Europe

Countries: Belgium

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Major Global Story

Source link

Show More

Related Articles

Αφήστε μια απάντηση

Η ηλ. διεύθυνση σας δεν δημοσιεύεται. Τα υποχρεωτικά πεδία σημειώνονται με *

Back to top button
Close
Close